Cipla Ltd., a global pharmaceutical company, has announced the allotment of 17,064 equity shares under its Employee Stock Option Scheme 2013-A (ESOS) and the Cipla Employee Stock Appreciation Rights (ESAR) Scheme 2021. This move was approved by the Operations and Administrative Committee of the company on November 15, 2024.

The allotment of these shares follows the exercise of employee stock options and stock appreciation rights by eligible employees under the aforementioned schemes. As a result, Cipla's issued, subscribed, and paid-up share capital has increased to INR 1,61,52,25,016. This includes a total of 80,76,12,508 equity shares with a face value of INR 2 each.

This step is part of Cipla’s ongoing commitment to employee retention and motivation through stock-based compensation schemes, which align employee interests with the long-term success of the company. The ESOS and ESAR schemes were designed to offer employees a stake in the company, incentivizing them to contribute toward Cipla's growth and success.

Key Updates:

1. Increase in Share Capital
   Following the allotment of 17,064 shares, Cipla's total issued share capital has risen to INR 1,61,52,25,016, comprising 80,76,12,508 equity shares with a face value of INR 2 each.

2. Employee Stock Options
   The shares were allotted as part of the ESOS 2013-A and Cipla ESAR Scheme 2021, under which employees were granted stock options and stock appreciation rights. These schemes are designed to reward employees for their contributions to the company’s growth.

3. BSE and NSE Filing
   Cipla has made this allotment public through filings with the BSE and NSE, as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

About Cipla Ltd.
Cipla Ltd. is a leading global pharmaceutical company headquartered in Mumbai, India. The company specializes in the development and manufacturing of generic medicines and active pharmaceutical ingredients (APIs), serving a wide range of therapeutic areas such as respiratory, cardiovascular, oncology, and more. With a commitment to innovation and accessibility, Cipla has become a trusted name in healthcare globally. The company is listed on the BSE and NSE, and its shares are widely held by institutional and retail investors.

This allotment is one of the many ways Cipla continues to engage its workforce, ensuring that its employees have a vested interest in the company’s performance and success.

The Upcoming IPOs in this week and coming weeks are Lomosaic India, C2C Advanced System, Rosmerta Digital, NTPC Green, Avanse Financial and Nisus Finance.

The Current active IPO are Zinka Logistics Solution (Black Buck), and Onyx Biotec.

For more insights into financial trends , visit our Top News Headlines. You can also explore investment opportunities in the market and apply for upcoming IPOs through our Best IPO to Apply Now section.